Laura König, PhD candidate in the Albers Lab, was invited to present her work on TYK2 as a novel drug target in neurodegeneration at the 36th International Symposium on ALS/MND in San Diego (Dec 5–7, 2025). We thank the organizers and research community for the engaging discussions and interest.
